198 results
424B5
RVNC
Revance Therapeutics Inc
5 Mar 24
Prospectus supplement for primary offering
5:00pm
in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.
Special … by the applicable prospectus supplement. When a global security terminates, the depositary, and neither we nor any applicable trustee, is responsible
424B5
bohvr0yvfhoo97
4 Mar 24
Prospectus supplement for primary offering
6:39am
8-K
EX-10.2
ms5y2q
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
qcw0loln9l w3mtre
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
ty5a19i8nze01 1t
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
S-3ASR
EX-4.8
t6gbmt
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
EX-4.7
kzp0uow8kb 0oeck
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
EX-4.6
j8eatv94s l69e6
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
aip8cu64qam
14 Nov 23
Automatic shelf registration
4:22pm